Lv3
290 积分 2023-03-28 加入
An open‐label, prospective trial to evaluate the efficacy and safety of ixazomib in combination with cyclophosphamide and dexamethasone in patients with newly diagnosed POEMS syndrome
9分钟前
已完结
Impact of cytogenetic abnormalities on treatment outcomes in patients with amyloid light-chain amyloidosis: subanalyses from the ANDROMEDA study
3个月前
已完结
A real‐life study of daratumumab combinations in newly diagnosed patients with light chain (AL) amyloidosis
3个月前
已完结
Bone marrow tracer uptake pattern of PET-CT in multiple myeloma: image interpretation and prognostic value
3个月前
已完结
Development of Imaging Endpoints for Clinical Trials in AL and ATTR Amyloidosis
4个月前
已完结
Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
4个月前
已完结
Measurable Residual Disease–Guided Therapy in Newly Diagnosed Myeloma
4个月前
已完结
Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia
4个月前
已完结
Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group
4个月前
已完结
Neurological complications of CAR T cell therapy for cancers
4个月前
已完结
皖公网安备34019202002308
